Preclinical Assessment of Ketamine

CNS Neuroscience and Therapeutics

Volumn 19, Issue 6, 2013, Pages 448-453

  Wang, Cheng ^a   Liu, Fang ^a   Patterson, Tucker A ^a   Paule, Merle G ^a   Slikker Jr , William ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Antioxidants; Development; Ketamine; Neurodegeneration; Neuroprotection; NMDA receptor; Reactive oxygen species

Indexed keywords

ANTIOXIDANT; CALCIUM; GLUTAMATE RECEPTOR; KETAMINE;

ANESTHESIA; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BRAIN DEVELOPMENT; CALCIUM TRANSPORT; COGNITIVE DEFECT; DEVELOPMENTAL BIOLOGY; DRUG EXPOSURE; DRUG MECHANISM; DRUG SCREENING; EXCITOTOXICITY; INFLAMMATION; NERVE CELL; NERVE CELL NECROSIS; NEURAL STEM CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; REVIEW;

ANIMALS; BRAIN DISEASES; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; HUMANS; KETAMINE; NEUROPROSTANES;

EID: 84878153366     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12079     Document Type: Review

References (78)

1. Deasy C, Babl FE. Intravenous vs intramuscular ketamine for pediatric procedural sedation by emergency medicine specialists: a review. Paediatr Anaesth 2010;20:787-796.
2. Muir WW. NMDA receptor antagonists and pain: ketamine. Vet Clin North Am Equine Pract 2010;26:565-578.
3. Reynaud-Maurupt C, Bello PY, Akoka S, Toufik A. Characteristics and behaviors of ketamine users in France in 2003. J Psychoactive Drugs 2007;39:1-11.
4. Bubenikova-Valesova V, Horacek J, Vrajova M, Hoschl C. Models of schizophrenia in humans and animals based on inhibition of NMDA receptors. Neurosci Biobehav Rev 2008;32:1014-1023.
5. Machado-Vieira R, Salvadore G, Diazgranados N, Zarate CA Jr. Ketamine and the next generation of antidepressants with a rapid onset of action. Pharmacol Ther 2009;123:143-150.
6. Krystal JH, Mathew SJ, D'Souza DC, Garakani A, Gunduz-Bruce H, Charney DS. Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists. CNS Drugs 2010;24:669-693.
7. Collingridge GL, Kehl SJ, McLennan H. Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus. J Physiol 1983;334:33-46.
8. Meldrum B, Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 1990;11:379-387.
9. D'Souza SW, McConnell SE, Slater P, Barson AJ. Glycine site of the excitatory amino acid N-methyl-D-aspartate receptor in neonatal and adult brain. Arch Dis Child 1993;69:212-215.
10. Muller D, Wang C, Skibo G, et al. PSA-NCAM is required for activity-induced synaptic plasticity. Neuron 1996;17:413-422.
11. Bhutta AT, Schmitz ML, Swearingen C, et al. Ketamine as a neuroprotective and anti-inflammatory agent in children undergoing surgery on cardiopulmonary bypass: a pilot randomized, double-blind, placebo-controlled trial. Pediatr Crit Care Med 2012;13:328-337.
12. Anand KJ, Garg S, Rovnaghi CR, Narsinghani U, Bhutta AT, Hall RW. Ketamine reduces the cell death following inflammatory pain in newborn rat brain. Pediatr Res 2007;62:283-290.
13. Kari HP, Davidson PP, Kohl HH, Kochhar MM. Effects of ketamine on brain monoamine levels in rats. Res Commun Chem Pathol Pharmacol 1978;20:475-488.
14. Wakschlag LS, Kistner EO, Pine DS, et al. Interaction of prenatal exposure to cigarettes and MAOA genotype in pathways to youth antisocial behavior. Mol Psychiatry 2010;15:928-937.
15. Medeiros LF, Rozisky JR, de Souza A, et al. Lifetime behavioural changes after exposure to anaesthetics in infant rats. Behav Brain Res 2011;218:51-56.
16. Ikonomidou C, Bosch F, Miksa M, et al. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 1999;283:70-74.
17. Scallet AC, Schmued LC, Slikker W Jr, et al. Developmental neurotoxicity of ketamine: morphometric confirmation, exposure parameters, and multiple fluorescent labeling of apoptotic neurons. Toxicol Sci 2004;81:364-370.
18. Slikker W Jr, Zou X, Hotchkiss CE, et al. Ketamine-induced neuronal cell death in the perinatal rhesus monkey. Toxicol Sci 2007;98:145-158.
19. Zou X, Patterson TA, Divine RL, et al. Prolonged exposure to ketamine increases neurodegeneration in the developing monkey brain. Int J Dev Neurosci 2009a;27:727-731.
20. Zou X, Patterson TA, Sadovova N, et al. Potential neurotoxicity of ketamine in the developing rat brain. Toxicol Sci 2009b;108:149-158.
21. Shi Q, Guo L, Patterson TA, et al. Gene expression profiling in the developing rat brain exposed to ketamine. Neuroscience 2010;166:852-863.
22. Luciana M, Lindeke L, Georgieff M, Mills M, Nelson CA. Neurobehavioral evidence for working-memory deficits in school-aged children with histories of prematurity. Dev Med Child Neurol 1999;41:521-533.
23. Peterson BS, Vohr B, Kane MJ, et al. A functional magnetic resonance imaging study of language processing and its cognitive correlates in prematurely born children. Pediatrics 2002;110:1153-1162.
24. Peterson BS, Vohr B, Staib LH, et al. Regional brain volume abnormalities and long-term cognitive outcome in preterm infants. JAMA 2000;284:1939-1947.
25. Bhutta AT, Cleves MA, Casey PH, Cradock MM, Anand KJ. Cognitive and behavioral outcomes of school-aged children who were born preterm: a meta-analysis. JAMA 2002;288:728-737.
26. Bhutta AT, Anand KJ. Abnormal cognition and behavior in preterm neonates linked to smaller brain volumes. Trends Neurosci 2001;24:129-130, discussion 31-2.
27. Rovnaghi CR, Garg S, Hall RW, Bhutta AT, Anand KJ. Ketamine analgesia for inflammatory pain in neonatal rats: a factorial randomized trial examining long-term effects. Behav Brain Funct 2008;4:35.
28. Brambrink AM, Evers AS, Avidan MS, et al. Isoflurane-induced neuroapoptosis in the neonatal rhesus macaque brain. Anesthesiology 2010;112:834-841.
29. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988;1:623-634.
30. Jevtovic-Todorovic V, Hartman RE, Izumi Y, et al. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci 2003;23:876-882.
31. Wang C, Sadovova N, Fu X, et al. The role of the N-methyl-D-aspartate receptor in ketamine-induced apoptosis in rat forebrain culture. Neuroscience 2005;132:967-977.
32. Wang C, Sadovova N, Hotchkiss C, et al. Blockade of N-methyl-D-aspartate receptors by ketamine produces loss of postnatal day 3 monkey frontal cortical neurons in culture. Toxicol Sci 2006;91:192-201.
33. Furukawa H, Singh SK, Mancusso R, Gouaux E. Subunit arrangement and function in NMDA receptors. Nature 2005;438:185-192.
34. Laube B, Kuhse J, Betz H. Evidence for a tetrameric structure of recombinant NMDA receptors. J Neurosci 1998;18:2954-2961.
35. Premkumar LS, Auerbach A. Stoichiometry of recombinant N-methyl-D-aspartate receptor channels inferred from single-channel current patterns. J Gen Physiol 1997;110:485-502.
36. Ulbrich MH, Isacoff EY. Subunit counting in membrane-bound proteins. Nat Methods 2007;4:319-321.
37. Grant IS, Nimmo WS, Clements JA. Lack of effect of ketamine analgesia on gastric emptying in man. Br J Anaesth 1981;53:1321-1323.
38. Clements JA, Nimmo WS. Pharmacokinetics and analgesic effect of ketamine in man. Br J Anaesth 1981;53:27-30.
39. Anand KJ, Soriano SG. Anesthetic agents and the immature brain: are these toxic or therapeutic? Anesthesiology 2004;101:527-530.
40. Zilberstein G, Levy R, Rachinsky M, et al. Ketamine attenuates neutrophil activation after cardiopulmonary bypass. Anesth Analg 2002;95:531-536, table of contents.
41. Roytblat L, Talmor D, Rachinsky M, et al. Ketamine attenuates the interleukin-6 response after cardiopulmonary bypass. Anesth Analg 1998;87:266-271.
42. Lewis E, Rogachev B, Shaked G, Douvdevani A. The in vitro effects of ketamine at large concentrations can be attributed to a nonspecific cytostatic effect. Anesth Analg 2001;92:927-929.
43. Lees GJ. Influence of ketamine on the neuronal death caused by NMDA in the rat hippocampus. Neuropharmacology 1995;34:411-417.
44. Roytblat L, Bear R, Gesztes T. Seizures after pentazocine overdose. Isr J Med Sci 1986;22:385-386.
45. Ikonomidou C, Bittigau P, Koch C, et al. Neurotransmitters and apoptosis in the developing brain. Biochem Pharmacol 2001;62:401-405.
46. Olney JW, Wozniak DF, Jevtovic-Todorovic V, Farber NB, Bittigau P, Ikonomidou C. Drug-induced apoptotic neurodegeneration in the developing brain. Brain Pathol 2002;12:488-498.
47. Clancy B, Finlay BL, Darlington RB, Anand KJ. Extrapolating brain development from experimental species to humans. Neurotoxicology 2007;28:931-937.
48. Haberny KA, Paule MG, Scallet AC, et al. Ontogeny of the N-methyl-D-aspartate (NMDA) receptor system and susceptibility to neurotoxicity. Toxicol Sci 2002;68:9-17.
49. Huntley GW, Vickers JC, Morrison JH. Quantitative localization of NMDAR1 receptor subunit immunoreactivity in inferotemporal and prefrontal association cortices of monkey and human. Brain Res 1997;749:245-262.
50. Yon JH, Daniel-Johnson J, Carter LB, Jevtovic-Todorovic V. Anesthesia induces neuronal cell death in the developing rat brain via the intrinsic and extrinsic apoptotic pathways. Neuroscience 2005;135:815-827.
51. Liu F, Patterson TA, Sadovova N, et al. Ketamine-induced neuronal damage and altered N-methyl-D-aspartate (NMDA) receptor function in rat primary forebrain culture. Toxicol Sci 2013;131:548-557.
52. Barreto-Chang OL, Dolmetsch RE. Calcium imaging of cortical neurons using Fura-2 AM. J Vis Exp 2009;23:1067.
53. Lynch DR, Guttmann RP. Excitotoxicity: perspectives based on N-methyl-D-aspartate receptor subtypes. J Pharmacol Exp Ther 2002;300:717-723.
54. Irifune M, Shimizu T, Nomoto M, Fukuda T. Ketamine-induced anesthesia involves the N-methyl-D-aspartate receptor-channel complex in mice. Brain Res 1992;596:1-9.
55. Paule MG. Validation of a behavioral test battery for monkeys. In: Buccafusco JJ, ed. Methods of behavioral analysis in neuroscience. Boca Raton, FL: CRC Press LLC, 2001;281-294.
56. Paule MG, Forrester TM, Maher MA, Cranmer JM, Allen RR. Monkey versus human performance in the NCTR Operant Test Battery. Neurotoxicol Teratol 1990;12:503-507.
57. Paule MG, Li M, Allen RR, et al. Ketamine anesthesia during the first week of life can cause long-lasting cognitive deficits in rhesus monkeys. Neurotoxicol Teratol 2011;33:220-230.
58. Paule MG, Chelonis JJ, Buffalo EA, Blake DJ, Casey PH. Operant test battery performance in children: correlation with IQ. Neurotoxicol Teratol 1999;21:223-230.
59. Zhang X, Paule MG, Newport GD, et al. A minimally invasive, translational biomarker of ketamine-induced neuronal death in rats: microPET Imaging using 18F-annexin V. Toxicol Sci 2009;111:355-361.
60. Zhang X, Paule MG, Newport GD, et al. MicroPET imaging of ketamine-induced neuronal apoptosis with radiolabeled DFNSH. J Neural Transm 2011;118:203-211.
61. Zhang X, Paule MG, Newport GD, et al. MicroPET/CT imaging of [18F]-FEPPA in the nonhuman primate: a potential biomarker of pathogenic processes associated with anesthetic-induced neurotoxicity. ISRN Anesthesiology 2012; doi:10.5402/2012/261640.
62. Sanchez V, Feinstein SD, Lunardi N, et al. General anesthesia causes long-term impairment of mitochondrial morphogenesis and synaptic transmission in developing rat brain. Anesthesiology 2011;115:992-1002.
63. Boscolo A, Starr JA, Sanchez V, et al. The abolishment of anesthesia-induced cognitive impairment by timely protection of mitochondria in the developing rat brain: the importance of free oxygen radicals and mitochondrial integrity. Neurobiol Dis 2012;45:1031-1041.
64. Brookes P, Darley-Usmar VM. Hypothesis: the mitochondrial NO(*) signaling pathway, and the transduction of nitrosative to oxidative cell signals: an alternative function for cytochrome C oxidase. Free Radic Biol Med 2002;32:370-374.
65. Brookes PS, Levonen AL, Shiva S, Sarti P, Darley-Usmar VM. Mitochondria: regulators of signal transduction by reactive oxygen and nitrogen species. Free Radic Biol Med 2002;33:755-764.
66. Blaylock M, Engelhardt T, Bissonnette B. Fundamentals of neuronal apoptosis relevant to pediatric anesthesia. Paediatr Anaesth 2010;20:383-395.
67. Bosnjak ZJ, Yan Y, Canfield S, et al. Ketamine induces toxicity in human neurons differentiated from embryonic stem cells via mitochondrial apoptosis pathway. Curr Drug Saf 2012;7:106-119.
68. Zhang Y, Dong Y, Wu X, et al. The mitochondrial pathway of anesthetic isoflurane-induced apoptosis. J Biol Chem 2010;285:4025-4037.
69. Gincel D, Zaid H, Shoshan-Barmatz V. Calcium binding and translocation by the voltage-dependent anion channel: a possible regulatory mechanism in mitochondrial function. Biochem J 2001;358:147-155.
70. Zou X, Sadovova N, Patterson TA, et al. The effects of L-carnitine on the combination of, inhalation anesthetic-induced developmental, neuronal apoptosis in the rat frontal cortex. Neuroscience 2008;151:1053-1065.
71. Sohal RS, Allen RG. Relationship between metabolic rate, free radicals, differentiation and aging: a unified theory. Basic Life Sci 1985;35:75-104.
72. Perez-Campo R, Lopez-Torres M, Cadenas S, Rojas C, Barja G. The rate of free radical production as a determinant of the rate of aging: evidence from the comparative approach. J Comp Physiol B 1998;168:149-158.
73. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J 2001;357:593-615.
74. Cleeter MW, Cooper JM, Darley-Usmar VM, Moncada S, Schapira AH. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett 1994;345:50-54.
75. Yon JH, Carter LB, Reiter RJ, Jevtovic-Todorovic V. Melatonin reduces the severity of anesthesia-induced apoptotic neurodegeneration in the developing rat brain. Neurobiol Dis 2006;21:522-530.
76. Wang C, McInnis J, West JB, et al. Blockade of phencyclidine-induced cortical apoptosis and deficits in prepulse inhibition by M40403, a superoxide dismutase mimetic. J Pharmacol Exp Ther 2003;304:266-271.
77. Wang C, Sadovova N, Patterson TA, et al. Protective effects of 7-nitroindazole on ketamine-induced neurotoxicity in rat forebrain culture. Neurotoxicology 2008;29:613-620.
78. Friedman R. Hypothermia approach may avoid apoptosis from anesthesia in children. Neurology Today 2009;9:19-20.